Khilak forte solution cherry, 30ml

• violations of the physiological flora of the small and large intestine (during and after treatment with antibiotics or sulfonamides, radiation therapy);

• digestive insufficiency syndrome, dyspepsia;

• diarrhea, flatulence, constipation;

• gastroenteritis, colitis;

• senile bowel syndrome (chronic, atrophic gastroenteritis);

• disorders of the gastrointestinal tract caused by climate change;

• hypo- and anacid conditions;

• enterogenic diseases of the gallbladder and liver;

• allergic skin diseases (urticaria, endogenously caused chronic eczema);

• salmonellosis in the stage of convalescence (including in infants).

Hilak forte is taken orally before or during a meal, diluted in a small amount of liquid, excluding milk.

The drug is prescribed 3 times / day.

For adults, the drug is prescribed in 40-60 drops (2.2-3.3 ml) per dose; children - 20-40 drops (1.1-2.2 ml) per dose; babies - 15-30 drops per appointment.

In infants, it is recommended to use the drug in vials.

After improvement of the condition, the daily dose can be reduced by half.

100 ml

aqueous substrate of metabolic products of Escherichia coli DSM 4087 * - 24.9481 g

aqueous substrate of metabolic products Enterococcus faecalis DSM 4086 * - 12.4741 g

aqueous substrate of metabolic products Lactobacillus acidophilus DSM 4149 * - 12.4741 g

aqueous substrate of metabolic products Lactobacillus helveticus DSM 4183 * - 49.896 g

* substrates contain lactose.

Excipients: sodium phosphate heptahydrate - 1.159 g, dipotassium phosphate - 1.265 g, lactic acid - 2.5-6.25 g, concentrated phosphoric acid - 0.352 g, potassium sorbate - 0.1114 g, citric acid monohydrate - 0.0322 g, sodium saccharinate - 0.02 g, sodium cyclamate - 0.2 g, cream flavor - 0.2 g, cherry flavor - 0.5 g, water - up to 100 ml.

• hypersensitivity to drug components;

• lactase / isomaltase deficiency, lactose intolerance, glucose-galactose malabsorption.

Drops for oral administration (cherry flavor) in the form of a clear or slightly turbid yellowish-brown solution with a characteristic cherry smell.

100 ml

aqueous substrate of metabolic products of Escherichia coli DSM 4087 * - 24.9481 g

aqueous substrate of metabolic products Enterococcus faecalis DSM 4086 * - 12.4741 g

aqueous substrate of metabolic products Lactobacillus acidophilus DSM 4149 * - 12.4741 g

aqueous substrate of metabolic products Lactobacillus helveticus DSM 4183 * - 49.896 g

* substrates contain lactose.

Excipients: sodium phosphate heptahydrate - 1.159 g, dipotassium phosphate - 1.265 g, lactic acid - 2.5-6.25 g, concentrated phosphoric acid - 0.352 g, potassium sorbate - 0.1114 g, citric acid monohydrate - 0.0322 g, sodium saccharinate - 0.02 g, sodium cyclamate - 0.2 g, cream flavor - 0.2 g, cherry flavor - 0.5 g, water - up to 100 ml.

30 ml - dark glass vials (1) with dropper stopper and plastic cap with first opening control - cardboard packs.

100 ml - dark glass bottles (1) with dropper stopper and plastic cap with first opening control - cardboard packs.

Clinical and pharmacological group: A drug that regulates the balance of intestinal microflora

Pharmaco-therapeutic group: Antidiarrheal agent

pharmachologic effect

The natural physiological microflora of the intestine can be significantly disturbed by such external influences as antibiotic therapy, radiation, stomach surgery, as well as due to inappropriate and unusual nutrition, changes in water, climate change and other conditions.

Hilak forte regulates the balance of intestinal microflora and normalizes its composition. Due to the content of normal microflora metabolic products in the preparation, Hilak forte helps to restore normal intestinal microflora in a biological way and allows you to preserve the physiological and biological functions of the intestinal mucosa.

The biosynthetic lactic acid and its buffer salts, which are part of the preparation, restore the normal value of acidity in the gastrointestinal tract, regardless of whether the patient has increased or decreased acidity.

Against the background of the acceleration of the development of normal intestinal symbionts under the action of the drug Khilak forte, the natural synthesis of vitamins of the B and K groups is normalized. electrolyte balance in the intestinal lumen.

There is evidence that Hilak forte enhances the protective functions of the body by stimulating the immune response.

When using Khilak forte, an acceleration of the elimination of Salmonella in infants after salmonella enteritis is noted, which is due to the stimulation of the growth of acidophilic anaerobic flora and its subsequent antagonistic effect on salmonella.

Indications

• violations of the physiological flora of the small and large intestine (during and after treatment with antibiotics or sulfonamides, radiation therapy);

• digestive insufficiency syndrome, dyspepsia;

• diarrhea, flatulence, constipation;

• gastroenteritis, colitis;

• senile bowel syndrome (chronic, atrophic gastroenteritis);

• disorders of the gastrointestinal tract caused by climate change;

• hypo- and anacid conditions;

• enterogenic diseases of the gallbladder and liver;

• allergic skin diseases (urticaria, endogenously caused chronic eczema);

• salmonellosis in the stage of convalescence (including in infants).

Dosage regimen

Hilak forte is taken orally before or during a meal, diluted in a small amount of liquid, excluding milk.

The drug is prescribed 3 times / day.

For adults, the drug is prescribed in 40-60 drops (2.2-3.3 ml) per dose; children - 20-40 drops (1.1-2.2 ml) per dose; babies - 15-30 drops per appointment.

In infants, it is recommended to use the drug in vials.

After improvement of the condition, the daily dose can be reduced by half.

Side effect

To date, no adverse reactions have been observed.

From the digestive system: constipation, diarrhea are possible.

Allergic reactions: possible skin rash, itching, urticaria.

Hilak forte is well tolerated by patients of any age.

Contraindications for use

• hypersensitivity to drug components;

• lactase / isomaltase deficiency, lactose intolerance, glucose-galactose malabsorption.

Application during pregnancy and lactation

The use of the drug Hilak forte during pregnancy and lactation (breastfeeding) is considered safe. However, the decision on the appointment of the drug is made by the doctor.

Application in children

For children, the drug is prescribed 20-40 drops 3 times / day; babies - 15-30 drops 3 times / day. After improvement of the condition, the initial daily dose of Hilak forte can be reduced by half.

special instructions

It is not recommended to take the drug at the same time as milk and dairy products.

Influence on the ability to drive vehicles and mechanisms

The drug does not affect the ability to drive vehicles or engage in other potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions.

Overdose

No special measures are required other than routine medical supervision.

Drug interactions

With simultaneous use with antacid drugs, it is possible to neutralize lactic acid, which is part of the Hilak forte drug.

Storage conditions

The drug should be stored out of the reach of children at a temperature not exceeding 25 ? C.

Shelf life

The shelf life of the drug in a sachet is 2 years.

The shelf life of the drug in vials is 4 years; after opening the bottle - 6 weeks.

Terms of sale

The drug is dispensed without a prescription.